☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Iveric Bio
Iveric Bio Reports 24-Month Results of Izervay (avacincaptad pegol) for Geographic Atrophy
September 19, 2023
Iveric Bio Reports EMA Acceptance of MAA for Avacincaptad Pegol to Treat Geographic Atrophy
August 18, 2023
PharmaShots Weekly Snapshots (August 07–11, 2023)
August 12, 2023
Iveric Bio's Izervay (avacincaptad pegol intravitreal solution) Receives the US FDA’s Approval for the Treatment of Geographic Atr...
August 7, 2023
Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy
February 17, 2023
PharmaShots Weekly Snapshots (November 14 - 18 2022)
November 18, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.